Skip to main content
Terug
Watch Compare

BIOLARGO, INC.

Datakwaliteit: 83%
BLGO
OTC Manufacturing Chemicals
€ 0,14
▼ € 0,01 (-6,67%)
Marktkapitalisatie: 48,04 M
Prijs
€ 0,15
Marktkapitalisatie
48,04 M
Dagbereik
—
52-Weeksbereik
—
Volume
—
Openen —
50D / 200D Gem.
—
50D / 200D Gem.
—

Quick Summary

Belangrijkste Punten

Negative free cash flow of -8,30 M

Groei

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
-198,10%
Onder sectorgemiddelde (-53,53%)
ROIC-166,48%
Net MarginN/A
Op. MarginN/A

Veiligheid

Debt / Equity
N/A
Current Ratio1,67
Interest Coverage-27,51

Waardering

PE (TTM)
-3,16
Onder sectorgemiddelde (-1,48)
P/B Ratio7,30
EV/EBITDAN/A
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Manufacturing sector mediaan (1366 peers)
Metriek Aandeel Sector Mediaan
P/E -3,2 -1,5
P/B 7,3 1,6
ROE % -198,1 -53,5
Net Margin % — -41,5
Rev Growth 5Y % — 1,8
D/E — 0,3

Koersdoel Analisten

1 analist
Buy
Huidig
€ 0,14
+128.6%
Koersdoel
€ 0,32
€ 0,32
€ 0,32
€ 0,32
Vooruitzicht
Forward WPA -€ 0,04
Omzet Sch. 0,0

Winstschattingen

Periode WPA Sch. Omzet Sch. Analisten
FY2027 — 0,0 —
FY2026 -€ 0,05
-€ 0,05 – -€ 0,05
 3,61 M 1

Winstverassingen

Laatste 4 kwartalen
Kwartaal Geschat WPA Werkelijk WPA Verrassing
Q42025 -€ 0,01 -€ 0,01 +8,0%
Q32025 -€ 0,01 -€ 0,01 +15,0%
Q22025 -€ 0,01 € 0,00 +60,0%
Q12025 € 0,00 € 0,00 0,0%

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -15,19 M
ROE -198,10% ROA -140,45%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -8,30 M
ROIC -166,48% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 1,67
Interest Coverage -27,51 Asset Turnover N/A
Working Capital 2,32 M Tangible Book Value 6,58 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -3,16 Forward P/E N/A
P/B Ratio 7,30 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -17,27%
Market Cap 48,04 M Enterprise Value 43,49 M
Per Share
EPS (Diluted TTM) N/A Revenue / Share N/A
FCF / Share -0,03 OCF / Share -0,03
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 54,63%
SBC-Adj. FCF -10,49 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — — 12,23 M — —
Net Income -15,19 M -4,35 M -4,65 M -5,13 M -6,89 M
EPS (Diluted) — — — — —
Gross Profit 3,41 M 7,85 M 6,15 M 2,86 M 1,10 M
Operating Income -14,86 M -4,33 M -4,58 M -5,39 M -6,44 M
EBITDA — — — — —
R&D Expenses 2,59 M 2,88 M 2,28 M 1,32 M 1,37 M
SG&A Expenses 11,77 M 9,30 M 8,06 M 6,73 M 6,17 M
D&A — — 103.000,0 45.000,0 20.000,0
Interest Expense 540.000,0 66.000,0 91.000,0 53.000,0 234.000,0
Income Tax — 0,0 — — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 8,31 M 10,51 M 8,21 M 4,86 M 3,02 M
Total Liabilities 6,79 M 4,46 M 4,00 M 2,85 M 2,09 M
Shareholders' Equity 4,04 M 8,85 M 6,84 M 4,88 M 4,65 M
Total Debt 2,08 M 1,08 M 289.000,0 237.000,0 180.000,0
Cash & Equivalents 3,88 M 3,55 M 3,54 M 1,85 M 962.000,0
Current Assets 5,11 M 7,14 M 6,36 M 3,15 M 1,80 M
Current Liabilities 5,06 M 2,65 M 2,71 M 1,58 M 1,37 M